首页> 外文期刊>The Journal of arthroplasty >Periarticular Injection of Tranexamic Acid Reduces Blood Loss and the Necessity for Allogeneic Transfusion After Total Knee Arthroplasty Using Autologous Transfusion: A Retrospective Observational Study
【24h】

Periarticular Injection of Tranexamic Acid Reduces Blood Loss and the Necessity for Allogeneic Transfusion After Total Knee Arthroplasty Using Autologous Transfusion: A Retrospective Observational Study

机译:使用自体输血后,胞质注射促进的促进肺酸损失和对整膝关节置换术后同种异体输血的必要性:回顾性观测研究

获取原文
获取原文并翻译 | 示例
           

摘要

Abstract Background This study aimed to examine the influence of a periarticular injection of tranexamic acid (TXA) on blood loss after a total knee arthroplasty (TKA) in patients who received an autologous blood transfusion. Methods We retrospectively reviewed the medical charts of 82 patients (88 consecutive knees) who underwent a primary unilateral TKA with or without a periarticular TXA injection (TXA and control groups, respectively). All patients underwent an autologous blood transfusion. Perioperative parameters related to blood loss were compared between groups. Results Compared to the control group, the decrease in hemoglobin was significantly smaller in the TXA group (1.5 ± 1.2 vs 2.5 ± 1.4 g/dL, P P ?= .002). Moreover, the estimated blood loss, based on either hemoglobin or hematocrit, was significantly lower in the TXA group (509.8 ± 405.2 and 530.7 ± 418.5 mL, respectively) than in the control group (814.2 ± 543.8 and 809.1 ± 469.6 mL, respectively, both P Conclusion Periarticular TXA injection is effective in reducing postoperative blood loss and hemoglobin and hematocrit drops without increasing the risk of venous thrombosis or the necessity of an allogeneic blood transfusion.
机译:摘要背景本研究旨在探讨接受自体输血的患者全膝关节置换术(TKA)后促甲醛酸(TXA)对失血的影响。方法回顾性地审查了82名患者(连续88名膝盖)的医学图表,他们经历了或不分别存在荔枝型TXA注射(TXA和对照组)的主要单侧TKA。所有患者都经历了自体输血。在组之间比较了与血液损失相关的围手术期参数。结果与对照组相比,TXA组中血红蛋白的降低显着较小(1.5±1.2 Vs 2.5±1.4g / dL,P p?= .002)。此外,基于血红蛋白或血细胞比容的估计失血量显着低于对照组(分别为409.8±405.2和530.7±418.5mL)显着降低(分别为814.2±543.8和809.1±469.6ml, P末端Periarticular TXA注射都有效地减少术后失血和血红蛋白和血细胞比容下降,而不会增加静脉血栓形成的风险或同种异体输血的必要性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号